back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-11-18 11:15 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
877,500 | ||
| Filed 2021-02-27 11:50 Tx date 2021-02-08 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+11,363 vol |
11,363 | |
| Filed 2021-02-27 11:49 Tx date 2016-08-08 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-27 11:49 Tx date 2021-02-08 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-11,363 vol |
0 | |
| Filed 2020-11-17 20:31 Tx date 2020-11-16 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
1,033,334 | |
| Filed 2020-11-17 20:26 Tx date 2020-11-16 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |
2,061,333 | |
| Filed 2020-08-24 17:48 Tx date 2020-08-03 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+100,000 vol $0.21 each |
520,000 | |
| Filed 2020-07-10 20:36 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,500
+500,000 vol $0.025 each |
500,000 | |
| Filed 2020-07-10 20:36 Tx date 2015-06-05 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-10 20:30 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+400,000 vol $0.025 each |
1,861,333 | |
| Filed 2020-02-27 14:55 Tx date 2020-02-06 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$3,295
+11,363 vol $0.29 each |
11,363 | |
| Filed 2020-02-27 14:54 Tx date 2016-08-08 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-27 14:43 Tx date 2020-02-06 |
$EMH
Emerald Health Therapeutics, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,750
+75,000 vol $0.29 each |
420,000 | |
| Filed 2019-10-31 20:58 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,026,072 | |
| Filed 2019-08-15 17:29 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
833,334 | |
| Filed 2019-08-15 17:22 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
1,461,333 | |
| Filed 2019-08-07 17:18 Tx date 2019-07-19 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-60,300
-180,000 vol $0.335 each |
345,000 | |
| Filed 2019-07-26 13:33 Tx date 2019-07-19 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-60,300
-180,000 vol $0.335 each |
||
| Filed 2019-07-26 13:33 Tx date 2019-07-19 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-60,300
-180,000 vol $0.335 each |
345,000 | |
| Filed 2019-07-10 13:54 Tx date 2017-12-22 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$318,750
+75,000 vol $4.25 each |
325,000 | |
| Filed 2019-07-04 18:24 Tx date 2019-04-03 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$830,000
+200,000 vol $4.15 each |
450,000 | |
| Filed 2019-06-24 14:43 Tx date 2019-06-24 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-37,180
-169,000 vol $0.22 each |
876,072 | |
| Filed 2019-06-13 10:57 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+400,000 vol $0.06 each |
1,045,072 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,099
+358,571 vol $0.07 each |
961,333 | |
| Filed 2019-02-15 Tx date 2019-02-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,699
+73,928 vol $0.28 each |
602,762 | |
| Filed 2019-02-15 Tx date 2019-02-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,699.84
-73,928 vol $0.28 each |
645,072 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
528,834 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-28,820
-131,000 vol $0.22 each |
719,000 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+20,000 vol $0.125 each |
387,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+34,500 vol $0.10 each |
367,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+10,000 vol $0.125 each |
397,834 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
850,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
||
| Filed 2017-08-04 Tx date 2017-08-03 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+166,667 vol $0.15 each |
333,334 | |
| Filed 2017-08-04 Tx date 2017-08-03 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333
+166,667 vol $0.20 each |
333,334 | |
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+166,667 vol $0.15 each |
166,667 | |
| Filed 2017-06-28 Tx date 2015-06-05 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-26 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333
+166,667 vol $0.20 each |
166,667 | |
| Filed 2017-02-01 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-70,000 vol |
300,000 | |
| Filed 2017-01-30 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+300,000 vol $0.22 each |
370,000 | |
| Filed 2017-01-06 Tx date 2016-12-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-25,000
-12,500 vol $2.00 each |
0 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-210,000 vol |
70,000 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-37,500 vol |
12,500 | |
| Filed 2016-10-03 Tx date 2016-09-28 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 | |
| Filed 2016-08-29 Tx date 2016-08-08 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-29 Tx date 2016-08-26 |
$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+100,000 vol $0.35 each |
280,000 | |
| Filed 2016-01-04 Tx date 2015-12-30 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+100,000 vol $0.40 each |
180,000 | |
| Filed 2015-10-08 Tx date 2015-08-19 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$-144,000
-320,000 vol $0.45 each |
80,000 | |
| Filed 2015-10-08 Tx date 2015-08-19 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$-171,000
-380,000 vol $0.45 each |
||
| Filed 2015-07-02 Tx date 2015-06-05 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2015-07-02 Tx date 2015-06-05 |
$NPH
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2015-06-25 Tx date 2014-08-27 |
$VVV
Venturi Ventures Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-25 Tx date 2014-11-20 |
$VVV
Venturi Ventures Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+38,000 vol |
38,000 |